Home » Topics » BioWorld Science

BioWorld Science
RSS

HZN-7734 enters phase II study for SLE

June 30, 2021

FDA approves IND for phase I/II trial of ExoFlo for mild to moderate COVID-19

June 30, 2021

Endpoints not met in phase II trial of ANG-3777 in COVID-19-associated pneumonia

June 30, 2021

Altimmune discontinues AdCOVID development, updates T-COVID progress

June 30, 2021

Novel miRNAs found with prognostic value in heart failure

June 30, 2021

Dosing begins in phase Ib/II study of TTI-621 with doxorubicin in leiomyosarcoma

June 30, 2021

Trial finds rice-based oral cholera vaccine safe, effective

June 30, 2021

Elicio initiates phase I/II AMPLIFY-201 study of ELI-002 in KRAS-driven cancers

June 30, 2021

FDA clears IND application for CLN-619 for the treatment of solid tumors

June 30, 2021

Initial phase I data for VBI-2902a, an enveloped virus-like particle COVID-19 vaccine candidate

June 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...